Table 3.
Select clinical prognostic factors by race/ethnicity, After Breast Cancer Pooling Projecta
| Non-Hispanic White (n=12,015) | Non-Hispanic Black (n=357) | Hispanic (n=387) | Asian American (n=292) | Chinese (n=4,886) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |
| TNM Stage | ||||||||||
| I | 5,698 | (49.5) | 126 | (36.5) | 145 | (38.3) | 134 | (47.0) | 1,679 | (36.1) |
| II | 4,059 | (35.3) | 161 | (46.7) | 182 | (48.0) | 121 | (42.5) | 2,209 | (47.4) |
| III | 1,515 | (13.2) | 53 | (15.4) | 51 | (13.5) | 29 | (10.2) | 740 | (15.9) |
| IV | 239 | (2.1) | 5 | (1.5) | 1 | (0.3) | 1 | (0.4) | 28 | (0.6) |
| Missing | 504 | 12 | 8 | 7 | 230 | |||||
| ER/PR status | ||||||||||
| ER+/PR+ | 6,521 | (63.6) | 142 | (46.9) | 229 | (63.1) | 190 | (69.1) | 2,439 | (51.0) |
| ER+/PR− | 1,582 | (15.4) | 48 | (15.8) | 40 | (11.0) | 38 | (13.8) | 635 | (13.3) |
| ER−/PR+ | 338 | (3.3) | 16 | (5.3) | 14 | (3.9) | 10 | (3.6) | 362 | (7.6) |
| ER−/PR− | 1,810 | (17.7) | 97 | (32.0) | 80 | (22.0) | 37 | (13.5) | 1,350 | (28.2) |
| Missing | 1,764 | 54 | 24 | 17 | 100 | |||||
| HER2 | ||||||||||
| Positive | 532 | (11.7) | 33 | (15.6) | 37 | (13.5) | 41 | (20.4) | 837 | (30.5) |
| Negative | 3,736 | (82.1) | 164 | (77.4) | 225 | (82.1) | 155 | (77.1) | 1,689 | (61.4) |
| Indeterminate | 284 | (6.2) | 15 | (7.1) | 12 | (4.4) | 5 | (2.5) | 223 | (8.1) |
| Missing | 7,463 | 145 | 113 | 91 | 2,137 | |||||
| Chemotherapyb | ||||||||||
| No | 4,716 | (48.4) | 104 | (33.9) | 125 | (34.8) | 93 | (33.3) | 382 | (7.8) |
| Yes | 5,027 | (51.6) | 203 | (66.1) | 234 | (65.2) | 186 | (66.7) | 4,504 | (92.2) |
| Missing | 2,272 | 50 | 28 | 13 | 0 | |||||
| Radiotherapy | ||||||||||
| No | 4,030 | (40.6) | 111 | (35.9) | 140 | (38.8) | 124 | (44.9) | 3,286 | (67.3) |
| Yes | 5,897 | (59.4) | 198 | (64.1) | 221 | (61.2) | 152 | (55.1) | 1,600 | (32.8) |
| Missing | 2,088 | 48 | 26 | 16 | 0 | |||||
| Endocrine therapyb | ||||||||||
| No | 3,392 | (32.3) | 123 | (39.2) | 103 | (28.3) | 63 | (22.5) | 2,315 | (47.5) |
| Yes | 7,103 | (67.7) | 191 | (60.8) | 261 | (71.7) | 217 | (77.5) | 2,555 | (52.5) |
| Missing | 1,520 | 43 | 23 | 12 | 16 | |||||
a
Table excludes 371 women of other races/ethnicities.
b
Based on one measure at baseline/first post-diagnosis survey.